Upstream analysis of receptor tyrosine kinases (RTK) by the Intracellular Signaling Protein Panel showed overall low HER2 (Fig. 3, HER2 box plot under “Receptors”) but above average protein levels for MET in comparison to the BC cohort (MET box plot under ‘Other’). Here, ERBB2 is linked to breast cancer.